| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.0095 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0044 | 1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.0077 | 1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |